Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals
Alvotech (ALVO) and Teva Pharmaceuticals' (TEVA) US affiliate said Tuesday that Alvotech will manufacture a high-concentration interchangeable biosimilar to Humira for Quallent Pharmaceuticals, which
MT NewswiresApr 30 11:32 ET
Express News | Alvotech SA - Strategic Agreement Is in Alignment With Alvotech's U.S. Commercialization Agreement With Teva Pharmaceuticals
ReutersApr 30 04:00 ET
Express News | Alvotech SA - Alvotech Will Manufacture Its High-Concentration Interchangeable Biosimilar to Humira(®) (Adalimumab) for Quallent Pharmaceuticals
ReutersApr 30 04:00 ET
Express News | U.S. Commercialization Agreement With Quallent to Drive Patient Savings With First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (Adalimumab)
ReutersApr 30 04:00 ET
AbbVie Stock Slides 6% Amid Concerns About Falling Humira Sales
Seeking AlphaApr 26 14:09 ET
Alvotech's Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study
Alvotech (ALVO.IC) on Wednesday said the confirmatory clinical trial for its Simponi and Simponi Aria biosimilar candidate AVT05 showed positive results in treating patients with moderate to severe rh
MT NewswiresApr 24 08:07 ET
Express News | Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)
Moomoo 24/7Apr 24 04:02 ET
Express News | Alvotech SA - Confirmatory Clinical Safety and Efficacy Study for Avt05 Met Its Primary Endpoint in Patients With Moderate to Severe Rheumatoid Arthritis
Moomoo 24/7Apr 24 04:00 ET
Express News | Alvotech - Confirmatory Clinical Safety and Efficacy Study for Avt05, Met Its Primary Endpoint
Moomoo 24/7Apr 24 04:00 ET
Express News | Alvotech Announces Topline Results From a Confirmatory Clinical Study for Avt05, a Proposed Biosimilar for Simponi® (Golimumab)
Moomoo 24/7Apr 24 04:00 ET
Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)
TipRanksApr 23 06:07 ET
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%. The iShares Biotechnology ETF (IBB) dec
MT NewswiresApr 19 16:00 ET
Express News | Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US
Moomoo 24/7Apr 19 10:57 ET
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday.Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday's session after the company reported better-than-expe
BenzingaApr 19 10:40 ET
Express News | Alvotech SA - Long-Term Agreement With a Strategic Partner to Further Enhance Access to Adalimumab-Ryvk in U.S. Market
Moomoo 24/7Apr 19 06:11 ET
Express News | Alvotech SA - Teva Will Continue to Commercialize Adalimumab-Ryvk Under Simlandi Brand in U.s
Moomoo 24/7Apr 19 06:10 ET
Express News | Alvotech SA - Agreement Broadens Patient Access and Further Commitment to Availability of Vital Biologics in U.S. and Globally
Moomoo 24/7Apr 19 06:10 ET
Express News | Alvotech SA - Current Multi-Product Commercialization Partnership Between Teva Pharmaceuticals and Alvotech Remains Unchanged
Moomoo 24/7Apr 19 06:10 ET
Express News | Alvotech Signs U.S. Agreement to Expand Access for Newly Approved High-Concentration Interchangeable Biosimilar to Humira® (Adalimumab)
Moomoo 24/7Apr 19 06:10 ET
CVS Favors Humira Copycats Hurting AbbVie's Market Share: Evercore
Seeking AlphaApr 17 09:26 ET
No Data
No Data